Show notes
Hematology-Oncology News:
- Radiotherapy planning scans reveal breast cancer patients’ CVD risk (https://bit.ly/2FeoJiH)
- FDA OKs combination immunotherapy for first-line mesothelioma treatment (https://bit.ly/2Ff77mS)
- Apatinib plus gefitinib: Better PFS but more toxicity (https://bit.ly/34IyVsn)
- Atezolizumab strikes out in ovarian cancer (https://bit.ly/3iPjXG1)
Email Blood & Cancer at podcasts@mdedge.com and learn more at https://www.mdedge.com/podcasts/blood-cancer